All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

Amid a booming fertility market, Progyny is expanding its reach to touch areas like menopause and male infertility, CEO Pete Anevski tells Axios.

Why it matters: Globally, fertility alone is an $8 billion opportunity, while the surrounding reproductive market has gained significant traction as well.

Driving the news: Progyny reported Q3 earnings earlier this month, reporting a quarterly revenue boost of 37% to $281 million.

Adjusted EBITDA increased by 43% to $50 million.

What they're saying: "It does not seem like people are cutting back on benefits and we saw 20% of clients add an offering to their existing benefits," Anevski says.

"We will continue to explore other adjacencies that are focused on women's health or a segment that is underserved in women's health and also in family building," he says.

Progyny will launch products that address menopause, postpartum issues, maternal health, and pre-conception in January, with a male infertility offering planned after that.

What's next: While no acquisitions are imminently on Progyny's radar, the company continues to look at M&A regularly.

"Valuations continue to be frothy, given what's happening in the economy and funding, we will explore options and would love to find to something that makes sense."

Meanwhile, though Progyny started in the employer space, the company recently penetrated government plans.

"We got our foot in the door in the government space, with a population of 300,000 lives and this will be important for the future," Anevski says.

State of play: Next year will mark Progyny's ninth in the market — and over that almost decade, the fertility and family-building space has ballooned.

Cercle has raised $4.2 million to date, including backing from Sandberg Bernthal this month.

Sonio raised $14 million in Series A for prenatal screening in July.

Mate Fertility raised $5 million to tackle IVF provider shortage in May

Oula raised $19 million in Series A funding to flip the maternity care model in January.

Sunfish raised $4 million for fertility financing, also in January.

Progyny to birth new products across fertility, repro health

It reported Q3 earnings that saw a revenue boost of 37% and adjusted EBITDA increase by 43%.

Illustration of a pregnancy test with a dollar sign appearing on the screen.

Health tech deals

Amid a booming fertility market, Progyny is expanding its reach to touch areas like menopause and male infertility, CEO Pete Anevski tells Axios.Why it matters: Globally, fertility alone is an<a class="gtmContentClick" data-vars-link-text=" $8 billion opportunity" data-vars-click-url="https://link.axios.com/click/33431215.40/aHR0cHM6Ly93d3cuaGFycmlzd2lsbGlhbXMuY29tL291ci1pbnNpZ2h0cy9mZXJ0aWxpdHktbWFya2V0LW92ZXJ2aWV3LTE_dXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPXNlbmR0b19wcm9uZXdzbGV0dGVydGVzdCZzdHJlYW09dG9w/63d7efa24889932dcb08ba1cBc7901866" data-vars-content-id="98494497-a081-4774-b742-8da70c8bc113" data-vars-headline="Progyny to birth new products across fertility, repro health" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://link.axios.com/click/33431215.40/aHR0cHM6Ly93d3cuaGFycmlzd2lsbGlhbXMuY29tL291ci1pbnNpZ2h0cy9mZXJ0aWxpdHktbWFya2V0LW92ZXJ2aWV3LTE_dXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPXNlbmR0b19wcm9uZXdzbGV0dGVydGVzdCZzdHJlYW09dG9w/63d7efa24889932dcb08ba1cBc7901866" target="_self"> $8 billion opportunity</a>, while the surrounding reproductive market has gained <a class="gtmContentClick" data-vars-link-text="significant traction" data-vars-click-url="https://link.axios.com/click/33431215.40/aHR0cHM6Ly93d3cuYXhpb3MuY29tL3Byby9oZWFsdGgtdGVjaC1kZWFscy8yMDIzLzAyLzIzL2hvdC1hcmVhcy13b21lbnMtaGVhbHRoLXRlY2gtdG8td2F0Y2g_dXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPXNlbmR0b19wcm9uZXdzbGV0dGVydGVzdCZzdHJlYW09dG9w/63d7efa24889932dcb08ba1cB4c99f5bb" data-vars-content-id="98494497-a081-4774-b742-8da70c8bc113" data-vars-headline="Progyny to birth new products across fertility, repro health" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://link.axios.com/click/33431215.40/aHR0cHM6Ly93d3cuYXhpb3MuY29tL3Byby9oZWFsdGgtdGVjaC1kZWFscy8yMDIzLzAyLzIzL2hvdC1hcmVhcy13b21lbnMtaGVhbHRoLXRlY2gtdG8td2F0Y2g_dXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPXNlbmR0b19wcm9uZXdzbGV0dGVydGVzdCZzdHJlYW09dG9w/63d7efa24889932dcb08ba1cB4c99f5bb" target="_self">significant traction</a> as well.

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

boulder

detroit

kansas-city

columbus

austin

dallas

atlanta

washington-dc

nw-arkansas

chicago

indianapolis

nashville

richmond

colorado-springs

houston

san-francisco

seattle

boston

des-moines

salt-lake-city

philadelphia

denver

phoenix

new-orleans

miami

twin-cities

raleigh

san-antonio

portland

san-diego

tampa-bay

cleveland

huntsville

pittsburgh

axios-local

axios-pro

axios-live

the-axios-show

Progyny to birth new products across fertility, repro health

What to read next